• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾素血管紧张素系统的进展集中在血管紧张素转换酶2和血管紧张素-(1-7)上。

Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7).

作者信息

Ferrario Carlos M, Ahmad Sarfaraz, Joyner Janae, Varagic Jasmina

机构信息

Hypertension and Vascular Disease Research Center, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA;.

出版信息

Adv Pharmacol. 2010;59:197-233. doi: 10.1016/S1054-3589(10)59007-0.

DOI:10.1016/S1054-3589(10)59007-0
PMID:20933203
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5863743/
Abstract

The contribution of the renin angiotensin system to physiology and pathology is undergoing a rapid reconsideration of its mechanisms from emerging new concepts implicating angiotensin-converting enzyme 2 and angiotensin-(1-7) as new elements negatively influencing the vasoconstrictor, trophic, and pro-inflammatory actions of angiotensin II. This component of the system acts to oppose the vasoconstrictor and proliferative effects on angiotensin II through signaling mechanisms mediated by the mas receptor. In addition, a reduced expression of the vasodepressor axis composed by angiotensin-converting enzyme 2 and angiotensin-(1-7) may contribute to the expression of essential hypertension, the remodeling of heart and renal function associated with this disease, and even the physiology of pregnancy and the development of eclampsia.

摘要

肾素血管紧张素系统对生理和病理的作用正在经历机制上的快速重新审视,这源于新出现的概念,即血管紧张素转换酶2和血管紧张素-(1-7)作为新元素,对血管紧张素II的血管收缩、营养和促炎作用产生负面影响。该系统的这一组成部分通过mas受体介导的信号机制,对抗血管紧张素II的血管收缩和增殖作用。此外,由血管紧张素转换酶2和血管紧张素-(1-7)组成的血管舒张轴表达降低,可能导致原发性高血压的发生、与该疾病相关的心脏和肾功能重塑,甚至影响妊娠生理和子痫的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1362/5863743/8cca44099afb/nihms950229f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1362/5863743/8cca44099afb/nihms950229f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1362/5863743/8cca44099afb/nihms950229f1.jpg

相似文献

1
Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7).肾素血管紧张素系统的进展集中在血管紧张素转换酶2和血管紧张素-(1-7)上。
Adv Pharmacol. 2010;59:197-233. doi: 10.1016/S1054-3589(10)59007-0.
2
Opportunities for targeting the angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor pathway in hypertension.靶向血管紧张素转换酶 2/血管紧张素-(1-7)/Mas 受体途径治疗高血压的机遇。
Curr Hypertens Rep. 2013 Feb;15(1):31-8. doi: 10.1007/s11906-012-0324-1.
3
Emerging concepts about the renin angiotensin system: present and future clinical applications.肾素-血管紧张素系统的新观念:当前及未来的临床应用
East Afr Med J. 1996 Sep;73(9):607-10.
4
Recent advances in the renin-angiotensin system: angiotensin-converting enzyme 2 and (pro)renin receptor.肾素-血管紧张素系统的最新进展:血管紧张素转换酶2和(前)肾素受体
Exp Physiol. 2008 May;93(5):517-8. doi: 10.1113/expphysiol.2008.042861.
5
Blocking the tissue renin-angiotensin system: the future cornerstone of therapy.阻断组织肾素-血管紧张素系统:未来治疗的基石
J Hum Hypertens. 2000 Oct;14 Suppl 2:S23-31. doi: 10.1038/sj.jhh.1001070.
6
Discovery and characterization of alamandine: a novel component of the renin-angiotensin system.发现并鉴定阿马林:肾素-血管紧张素系统的新组成部分。
Circ Res. 2013 Apr 12;112(8):1104-11. doi: 10.1161/CIRCRESAHA.113.301077. Epub 2013 Feb 27.
7
Angiotensin-converting enzyme 2: a key enzyme in key organs.血管紧张素转化酶 2:关键器官中的关键酶。
J Cardiovasc Med (Hagerstown). 2022 Jan 1;23(1):1-11. doi: 10.2459/JCM.0000000000001218.
8
Novel aspects of the renal renin-angiotensin system: angiotensin-(1-7), ACE2 and blood pressure regulation.肾脏肾素-血管紧张素系统的新进展:血管紧张素-(1-7)、血管紧张素转换酶2与血压调节
Contrib Nephrol. 2004;143:77-89. doi: 10.1159/000078713.
9
Predominance of AT(1) blockade over mas-mediated angiotensin-(1-7) mechanisms in the regulation of blood pressure and renin-angiotensin system in mRen2.Lewis rats.在 mRen2.Lewis 大鼠血压和肾素-血管紧张素系统的调节中,AT(1) 阻断占主导地位,而 mas 介导的血管紧张素-(1-7) 机制则处于次要地位。
Am J Hypertens. 2013 May;26(5):583-90. doi: 10.1093/ajh/hps090. Epub 2013 Mar 4.
10
Tissue renin-angiotensin systems in the heart and vasculature: possible involvement in the cardiovascular actions of converting enzyme inhibitors.心脏和血管系统中的组织肾素-血管紧张素系统:可能参与血管紧张素转换酶抑制剂的心血管作用。
Am J Cardiol. 1990 May 22;65(19):3I-10I. doi: 10.1016/0002-9149(90)90118-k.

引用本文的文献

1
Targeting the epidermal growth factor receptor (EGFR/ErbB) for the potential treatment of renal pathologies.靶向表皮生长因子受体(EGFR/ErbB)用于肾脏疾病的潜在治疗。
Front Pharmacol. 2024 Aug 21;15:1394997. doi: 10.3389/fphar.2024.1394997. eCollection 2024.
2
Alternative Renin-Angiotensin System.替代肾素-血管紧张素系统。
Hypertension. 2024 May;81(5):964-976. doi: 10.1161/HYPERTENSIONAHA.123.21364. Epub 2024 Feb 16.
3
The role of captopril in leukotriene deficient type 1 diabetic mice.卡托普利在白三烯缺乏 1 型糖尿病小鼠中的作用。

本文引用的文献

1
The ANG-(1-7)/ACE2/mas axis in the regulation of nephron function.ANG-(1-7)/ACE2/mas 轴在肾单位功能调节中的作用。
Am J Physiol Renal Physiol. 2010 Jun;298(6):F1297-305. doi: 10.1152/ajprenal.00110.2010. Epub 2010 Apr 7.
2
Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease.ACE2 和血管紧张素-(1-7)在早期慢性肾脏病小鼠模型中的作用。
Am J Physiol Renal Physiol. 2010 Jun;298(6):F1523-32. doi: 10.1152/ajprenal.00426.2009. Epub 2010 Mar 31.
3
ACE2 and angiotensin 1-7 are increased in a human model of cardiovascular hyporeactivity: pathophysiological implications.
Sci Rep. 2023 Dec 13;13(1):22105. doi: 10.1038/s41598-023-49449-8.
4
Regulation of vascular angiotensin II type 1 and type 2 receptor and angiotensin-(1-7)/MasR signaling in normal and hypertensive pregnancy.正常妊娠和高血压妊娠中血管紧张素 II 型 1 和 2 型受体及血管紧张素-(1-7)/MasR 信号的调节。
Biochem Pharmacol. 2024 Feb;220:115963. doi: 10.1016/j.bcp.2023.115963. Epub 2023 Dec 5.
5
Renal Denervation Influences Angiotensin II Types 1 and 2 Receptors.肾去神经支配影响血管紧张素II 1型和2型受体。
Int J Nephrol. 2022 Oct 10;2022:8731357. doi: 10.1155/2022/8731357. eCollection 2022.
6
SARS-CoV-2 interacts with renin-angiotensin system: impact on the central nervous system in elderly patients.SARS-CoV-2 与肾素-血管紧张素系统相互作用:对老年患者中枢神经系统的影响。
Geroscience. 2022 Apr;44(2):547-565. doi: 10.1007/s11357-022-00528-0. Epub 2022 Feb 14.
7
Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA).心血管疾病与 COVID-19:ESC 冠状动脉病理生理学和微循环工作组、ESC 血栓形成工作组以及急性心血管护理协会(ACVC)与欧洲心律协会(EHRA)合作的共识文件。
Cardiovasc Res. 2021 Dec 17;117(14):2705-2729. doi: 10.1093/cvr/cvab298.
8
The Role of Epidermal Growth Factor Receptor Family of Receptor Tyrosine Kinases in Mediating Diabetes-Induced Cardiovascular Complications.受体酪氨酸激酶表皮生长因子受体家族在介导糖尿病诱发的心血管并发症中的作用
Front Pharmacol. 2021 Aug 2;12:701390. doi: 10.3389/fphar.2021.701390. eCollection 2021.
9
ACE2 interaction with cytoplasmic PDZ protein enhances SARS-CoV-2 invasion.血管紧张素转换酶2(ACE2)与细胞质PDZ蛋白的相互作用增强了新型冠状病毒2(SARS-CoV-2)的入侵。
iScience. 2021 Jul 23;24(7):102770. doi: 10.1016/j.isci.2021.102770. Epub 2021 Jun 24.
10
The Angiotensin-(1-12)/Chymase axis as an alternate component of the tissue renin angiotensin system.血管紧张素-(1-12)/糜酶轴作为组织肾素血管紧张素系统的替代成分。
Mol Cell Endocrinol. 2021 Jun 1;529:111119. doi: 10.1016/j.mce.2020.111119. Epub 2020 Dec 10.
ACE2 和血管紧张素 1-7 在心血管反应低下的人体模型中增加:病理生理学意义。
J Nephrol. 2010 Jul-Aug;23(4):472-7.
4
Regulation of angiotensin converting enzyme II by angiotensin peptides in human cardiofibroblasts.血管紧张素转换酶 II 在人心脏成纤维细胞中被血管紧张素肽调节。
Peptides. 2010 Jul;31(7):1334-40. doi: 10.1016/j.peptides.2010.03.026. Epub 2010 Mar 27.
5
High sucrose intake in rats is associated with increased ACE2 and angiotensin-(1-7) levels in the adipose tissue.大鼠高蔗糖摄入量与脂肪组织中血管紧张素转换酶2(ACE2)和血管紧张素-(1-7)水平升高有关。
Regul Pept. 2010 Jun 8;162(1-3):61-7. doi: 10.1016/j.regpep.2010.03.008. Epub 2010 Mar 24.
6
Inhibition of angiotensin-converting enzyme 2 exacerbates cardiac hypertrophy and fibrosis in Ren-2 hypertensive rats.血管紧张素转化酶 2 抑制可加重 Ren-2 高血压大鼠的心肌肥厚和纤维化。
Am J Hypertens. 2010 Jun;23(6):687-93. doi: 10.1038/ajh.2010.51. Epub 2010 Mar 18.
7
Lifetime overproduction of circulating Angiotensin-(1-7) attenuates deoxycorticosterone acetate-salt hypertension-induced cardiac dysfunction and remodeling.血管紧张素-(1-7)的终身过度产生可减轻盐皮质激素诱导的高血压引起的心脏功能障碍和重构。
Hypertension. 2010 Apr;55(4):889-96. doi: 10.1161/HYPERTENSIONAHA.110.149815. Epub 2010 Mar 8.
8
Improved lipid and glucose metabolism in transgenic rats with increased circulating angiotensin-(1-7).转基因大鼠循环血管紧张素-(1-7)增加可改善脂代谢和糖代谢。
Arterioscler Thromb Vasc Biol. 2010 May;30(5):953-61. doi: 10.1161/ATVBAHA.109.200493. Epub 2010 Mar 4.
9
Loss of ACE2 accelerates time-dependent glomerular and tubulointerstitial damage in streptozotocin-induced diabetic mice.血管紧张素转换酶 2 的缺失加速链脲佐菌素诱导的糖尿病小鼠肾小球和肾小管间质损伤的时间依赖性进展。
Hypertens Res. 2010 Apr;33(4):298-307. doi: 10.1038/hr.2009.231. Epub 2010 Feb 26.
10
[Relationship of angiotensin-converting enzyme 2 gene polymorphism with the prognosis of hypertensive stroke patients].血管紧张素转换酶2基因多态性与高血压性脑卒中患者预后的关系
Nan Fang Yi Ke Da Xue Xue Bao. 2010 Jan;30(1):84-7.